No Data
No Data
Baotou Dongbao Bio-tech (300239.SZ): A cumulative repurchase of 1.7812% of shares.
Gelonghui, May 6th丨Baotou Dongbao Bio-tech (300239.SZ) announced that as of April 30, 2025, the company has cumulatively repurchased 10,573,400 shares of the company through a dedicated securities account for share buybacks using centralized bidding method, accounting for 1.7812% of the company's current total share capital, with the highest Fill Price being 5.71 yuan/share, the lowest Fill Price being 4.59 yuan/share, and the total amount spent being 56,110,096.00 yuan (excluding trading fees). This buyback complies with the company's share buyback plan and relevant laws and regulations.
Baotou Dongbao Bio-tech: Summary of the 2024 Annual Report
Baotou Dongbao Bio-tech: 2025 First Quarter Report
Baotou Dongbao Bio-tech: 2024 Annual Report
Express News | Baotou Dongbao Bio-tech: In 2024, the net income is 85.9827 million yuan, a year-on-year decrease of 28.28%.
Baotou Dongbao Bio-tech (300239.SZ): The increase in tariffs has a relatively small impact on the company's overall performance.
On April 8, Glonghui reported that Baotou Dongbao Bio-tech (300239.SZ) stated on the investor interaction platform that the proportion of its exports to the USA in total revenue is relatively small, and the increase in tariffs has a minor impact on the company's overall performance.